Substance Name: Trastuzumab [USAN:INN:BAN]
RN: 180288-69-1
UNII: P188ANX8CK
Note
- A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.
Molecular Formula
- Unspecified
Classification Codes
- Antineoplastic Agents
- Antineoplastic Agents, Immunological
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Names and Synonyms
Name of Substance
- Trastuzumab
- Trastuzumab [USAN:INN:BAN]
MeSH Heading
- Trastuzumab
Synonyms
- 212Pb-TCMC-Trastuzumab
- Herceptin
- HSDB 8142
- Immunoglobulin G 1 (human-mouse monoclonal rhuMab HER2gamma1-chain antihuman p185(sup c-erbB2) receptor), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer
- MYL-1401O
- Ogivri
- PF 05280014
- rhumbAb 4D5
- Thiomab
- Trastuzumab
- Trastuzumab-dkst
- Trastuzumab-dkst [Olgivri]
- UNII-P188ANX8CK
Systematic Name
- Immunoglobulin G1, anti-(human p185neu receptor) (human-mouse monoclonal rhuMab HER2 gamma1-chain), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer
Registry Numbers
CAS Registry Number
- 180288-69-1
FDA UNII
- P188ANX8CK
System Generated Number
- 0180288691